Receivables rising with sales

Hong Kong IPO disclosure precedents · 281 companies, 282 items

Trade receivables/notes growing with business expansion and rising or fluctuating turnover days, generally within normal credit terms, with aging profile and subsequent settlement disclosed.

2026-09-30Application Proof
ACROBIOSYSTEMS CO., LTD北京百普赛斯生物科技股份有限公司

Our trade and notes receivables increased from RMB74.3 million as of December 31, 2023 to RMB100.9 million as of December 31, 2024, and further increased to RMB135.6 million as of December 31, 2025 and RMB174.7 million as of July 31, 2026 in line with the growth in our sales.

Financial Information · p. 226

The increase was primarily driven by our business scale expansion and sales growth, particularly the growth in overseas sales, for which the collection cycle is generally longer.

Financial Information · p. 227

We seek to maintain strict control over our outstanding receivables and have established credit control policies to minimize credit risk.

Financial Information · p. 227
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-09-30PHIP
Amicro Technology Co., Ltd.珠海一微科技股份有限公司

Our trade and bills receivables, net of impairment, increased to RMB78.3 million as of April 30, 2026, primarily in line with our revenue growth.

Financial Information · p. 262

Our trade and bills receivables turnover days increased from 54.9 days in 2025 to 65.1 days in the four months ended April 30, 2026, primarily because

Financial Information · p. 263

Our impairment losses under ECL model, net of reversal changed from reversal of impairment losses RMB0.9 million in the four months ended April 30, 2025 to impairment losses of RMB8.1 million in the four months ended April 30, 2026, primarily due to the net impairment losses recognized on trade and bills receivables, mainly attributable to (i) the increase in revenue by 50.7% in the four months ended April 30, 2026 compared to the corresponding period in 2025, which resulted in a larger balance of trade receivables; and (ii) a higher loss rate applied to balances from certain customers, taking into consideration their historical default patterns and the cessation of our business relationships with these customers.

Financial Information · p. 248
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-09-29Application Proof
DataCanvas Co., Ltd.北京九章云极科技股份有限公司

Our trade and bill receivables increased from RMB21.4 million as of December 31, 2023 to RMB33.0 million as of December 31, 2024, to RMB105.9 million as of December 31, 2025, and to RMB295.9 million as of June 30, 2026, primarily driven by the expansion of our business.

Financial Information · p. 214

Our trade and bill receivable turnover days increased from 27 days in 2025 to 69 days in the six months ended June 30, 2026, primarily due to an increase in our trade receivables balance as certain AI Computing Infrastructure Solutions projects were completed and accepted by customers toward the end of the period.

Financial Information · p. 215

As of July 31, 2026, approximately RMB34.6 million, or 10.7% of our trade and bill receivables outstanding as of June 30, 2026, had been subsequently settled.

Financial Information · p. 215
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-09-28Application Proof
Shandong Linuo Pharmaceutical Packaging Co.,Ltd.山东力诺医药包装股份有限公司

Our trade and notes receivables increased from RMB214.0 million as of December 31, 2023 to RMB254.1 million as of December 31, 2024, and further increased to RMB275.7 million as of December 31, 2025, primarily reflecting our business growth in 2024, as well as slower payments from certain pharmaceutical glass packaging customers in 2024 and 2025 amid the implementation of medical insurance cost control in the PRC.

Financial Information · p. 226

Our trade receivables turnover days increased from 69 days in 2024 to 86 days in 2025, consistent with the increase in our trade receivables balances resulting from our business growth and slower payments from certain pharmaceutical glass packaging customers.

Financial Information · p. 226

We have established credit control procedures to manage the recoverability of our trade and notes receivables.

Financial Information · p. 227
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-09-28PHIP
Anhui Sinomags Technology Co., Ltd安徽希磁科技股份有限公司

Our trade receivables amounted to RMB127.5 million, RMB133.8 million, RMB166.6 million and RMB238.8 million as of December 31, 2023, 2024 and 2025 and May 31, 2026, respectively.

Financial Information · p. 246

Our trade receivable turnover days were 100 days, 72 days, 67 days and 75 days in 2023, 2024 and 2025 and the five months ended May 31, 2026, respectively.

Financial Information · p. 246

To optimize our cash conversion cycle, we have implemented a comprehensive set of measures across our procurement, sales and finance functions.

Financial Information · p. 245
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-09-28Prospectus
Beijing ESWIN Computing Technology Co., Ltd.北京奕斯伟计算技术股份有限公司01256.HK

Our trade receivables increased to RMB1,112.2 million as of December 31, 2025 and decreased to RMB752.9 million as of March 31, 2026, primarily due to the settlement process of certain large amount of receivables recognized by the end of 2025 which was subsequently settled as of March 31, 2026.

Financial Information · p. 280

Our trade receivables turnover days increased to 170 days for the three months ended March 31, 2026, primarily because a relatively high amount of receivables in relation to a large-scale intelligent computing center solution was recognized by the end of March and was settled in July 2026, and certain payments from one customer were temporarily delayed due to overseas remittance process.

Financial Information · p. 281

As of July 31, 2026, RMB618.2 million, or 81.2% of our gross trade receivables as of March 31, 2026 had been subsequently settled.

Financial Information · p. 281
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-09-27Application Proof
Voyager Intelligent Systems Limited上海寅家电子科技股份有限公司

Our trade and bills receivables increased from RMB72.3 million as of December 31, 2023 to RMB114.4 million as of December 31, 2024, to RMB261.6 million as of December 31, 2025, and further to RMB311.6 million as of June 30, 2026, primarily due to the increased sales of our solutions and products as a result of our continuous business expansion and the Acquisition.

Financial Information · p. 231

Our trade and bills receivables turnover days increased from 142.8 days in 2025 to 154.3 days in the six months ended June 30, 2026, primarily due to the delayed payment by certain tier-one suppliers.

Financial Information · p. 232

As of the July 31, 2026, approximately RMB50.6 million, or 16.2% of our trade and bills receivables as of June 30, 2026 had been subsequently settled.

Financial Information · p. 232
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-09-25PHIP
Shenzhen Transsion Holdings Co., Ltd.深圳传音控股股份有限公司

Our trade receivables increased by 71.8% from RMB1,965.1 million as of December 31, 2023 to RMB3,376.5 million as of December 31, 2024, primarily due to the recognition of the trade receivables arising from transactions involving our former subsidiary in India following its disposal.

Financial Information · p. 232

Our trade receivables further increased by 10.4% to RMB3,726.3 million as of December 31, 2025 primarily because certain overseas customers adopt more sea freight instead of air freight shipping.

Financial Information · p. 233

As of July 31, 2026, RMB5,210.0 million, or 95.9%, of our trade receivables as of April 30, 2026, had been settled.

Financial Information · p. 234
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-09-21Application Proof
Dynamic Electronics Co., Ltd.超颖电子电路股份有限公司

Our trade and bills receivables increased from RMB998.6 million as of December 31, 2023 to RMB1,116.2 million as of December 31, 2024 and RMB1,374.4 million as of December 31, 2025, and further increased to RMB1,677.4 million as of June 30, 2026, primarily reflecting the expansion of our sales and the corresponding increase in customer receivable balances, as well as the timing of customer collections under our customary credit terms.

Financial Information · p. 179

We manage our credit risk through a customer credit-management system covering customer admission, credit approval, ongoing credit monitoring, periodic reconciliation and collection of overdue balances.

Financial Information · p. 179

As of July 31, 2026, RMB488.9 million, or 29.1%, of our trade receivables as of June 30, 2026, had been settled.

Financial Information · p. 180
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-09-21Prospectus
Shenzhen Kinwong Electronic Co., Ltd.深圳市景旺电子股份有限公司03228.HK

Our trade and bills receivables decreased by RMB190.1 million, or 3.9%, from RMB4,869.8 million as of December 31, 2025 to RMB4,679.6 million as of April 30, 2026, primarily due to our enhanced credit management measures.

Financial Information · p. 229

Our trade and bills receivable turnover days decreased from 129 days for the year ended December 31, 2023 to 119 days for the year ended December 31, 2024, and further decreased to 110 days for the year ended December 31, 2025, primarily due to our enhanced credit management on our receivables.

Financial Information · p. 230

As of July 31, 2026, RMB3,662.2 million, or 74.4%, of our trade and bills receivables as of April 30, 2026 had been settled.

Financial Information · p. 230
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-09-14Prospectus
Ligent Technologies, Inc.纳真科技公司09856.HK

Our relatively long trade and bills receivables turnover days during the Track Record Period was mainly attributable to our relatively high proportion of sales to customers in China with relatively long credit terms.

Financial Information · p. 211

Our trade and bills receivables turnover days decreased from 126.7 days in 2023 to 112.0 days in 2024 and further to 82.3 days in 2025 and to 71.0 days in the six months ended June 30, 2026, primarily due to increases in our revenue and our enhanced collection efforts.

Financial Information · p. 211

As of July 31, 2026, RMB1,171.1 million, or 48.6%, of our total trade and bills receivables outstanding as of June 30, 2026 had subsequently been collected.

Financial Information · p. 211
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-09-14Prospectus
Shenzhen Forms Syntron Information Co., Ltd.深圳四方精创资讯股份有限公司06700.HK

Our trade receivables turnover days increased from 74 days in 2024 to 100 days in 2025, primarily due to an increase in the balance of trade receivables to RMB203.7 million as of December 31, 2025.

Financial Information · p. 249

The increase in trade receivables was primarily attributable to the delayed payment process of one of our major customers, resulting in a slower pace of trade receivable collection and a higher year-end balance.

Financial Information · p. 250

As of July 31, 2026, RMB119.9 million, or 74.3% of our trade receivables as of March 31, 2026, had been settled.

Financial Information · p. 249
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-09-03Application Proof
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.深圳信立泰药业股份有限公司

Our trade and bills receivables increased by 10.6% from RMB467.4 million as of December 31, 2023 to RMB516.8 million as of December 31, 2024, and further increased by 39.6% from RMB516.8 million as of December 31, 2024 to RMB721.4 million as of December 31, 2025.

Financial Information · p. 237

Our trade and bills receivables turnover days remained relatively stable at 54 days, 47 days, 54 days, and 58 days in 2023, 2024, 2025, and the six months ended June 30, 2026, respectively.

Financial Information · p. 238

As of July 31, 2026, RMB386.3 million (before impairment), or 46.3%, of our gross trade and bills receivables as of June 30, 2026 had been subsequently settled.

Financial Information · p. 238
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-08-31Application Proof
ProteLight Pharmaceuticals (Jiangsu) Co., Ltd.普莱医药(江苏)股份有限公司

Our trade receivables turnover days increased from 172 days in 2024 to 223 days in 2025, primarily due to the decrease in revenue in 2025.

Financial Information · p. 235

As of August 24, 2026, RMB500.1 thousand, or 30.7%, of our trade and bill receivables as of June 30, 2026 had been subsequently settled.

Financial Information · p. 235
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-08-31Application Proof
Jiangxi Tongbo Technology Co., Ltd.江西铜博科技股份有限公司

Our trade and bills receivables turnover days increased from 132.2 days in 2023 to 165.9 days in 2024, primarily due to the continually long payment collection period as a result of the market slowdown in 2024.

Financial Information · p. 233

We had not experienced any material failure to collect trade and bills receivables from our customers during the Track Record Period and up to the Latest Practicable Date.

Financial Information · p. 233

As of July 31, 2026, approximately RMB349.5 million, or 31.7% of our trade and bills receivables as of June 30, 2026, had been subsequently settled.

Financial Information · p. 233
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-08-31Prospectus
Shenzhen Longsys Electronics Co., Ltd.深圳市江波龙电子股份有限公司09976.HK

As of December 31, 2023, 2024, 2025 and April 30, 2026, the balance of our trade and bills receivables amounted to RMB1,345.3 million, RMB1,671.6 million, RMB2,040.4 million and RMB3,642.9 million, respectively.

Financial Information · p. 264

In the four months ended April 30, 2026, our trade and bills receivables turnover days decreased to 23.2 days, primarily as more customers made prepayments to ensure supply in light of the robust market demand driven by AI-related investments.

Financial Information · p. 265

As of June 30, 2026, RMB2,900.5 million, or 79.7% of our trade and bills receivables outstanding as of April 30, 2026 had been subsequently collected.

Financial Information · p. 265
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-08-31Application Proof
Guangxi Yuchai Marine and Genset Power Co., Ltd.广西玉柴船电动力股份有限公司

Our trade and bills receivables increased by 54.0% from RMB1,022.5 million as of December 31, 2023 to RMB1,574.2 million as of December 31, 2024 and further increased by 55.4% to RMB2,446.9 million as of December 31, 2025, which is generally in line with our increased sales.

Financial Information · p. 250

Our trade and bills receivables increased by 56.4% from RMB2,446.9 million as of December 31, 2025 to RMB3,825.7 million as of June 30, 2026.

Financial Information · p. 250

Our average trade and bills receivables turnover days increased from 119 days in FY2025 to 126 days in 1H2026, primarily due to our increased sales of power generator sets for data center projects.

Financial Information · p. 251
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-08-28Application Proof
Zhejiang Chint Electrics Co., Ltd.浙江正泰电器股份有限公司

Trade and note receivables increased by 4.5% from RMB16,306.4 million as of December 31, 2023 to RMB17,042.4 million as of December 31, 2024, generally in line with revenue growth and the project-based nature of certain green energy solution businesses.

Financial Information · p. 189

We normally grant credit periods ranging from 30 days to 180 days to our customers.

Financial Information · p. 190

During the Track Record Period, we did not experience any significant losses associated with our trade and note receivables, and the fluctuation in our trade and note receivables did not have any material adverse impact on our liquidity or cash flows.

Financial Information · p. 190
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-08-28Application Proof
Nanjing Novlead Biotechnology Co., Ltd.南京诺令生物科技股份有限公司

The trade receivables turnover days increased from 3 days in 2024 to 21 days in 2025, mainly due to the increase in trade receivables in connection with overseas product sales and our provision of technical services.

Financial Information · p. 250

During the Track Record Period, we required the substantial majority of our domestic distributors to pay for our products before delivery and only granted credit terms to certain domestic and overseas distributors.

Financial Information · p. 250

Within 90 days | – | 7,392 | 6,757

Financial Information · p. 249
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-08-28Application Proof
Betta Pharmaceuticals Co., Ltd.贝达药业股份有限公司

Our trade receivables increased from RMB98.5 million as of December 31, 2024 to RMB351.3 million as of December 31, 2025, and further increased to RMB624.9 million as of June 30, 2026 primarily due to our increased sales volume.

Financial Information · p. 234

Our average trade receivables turnover days increased from 23 days in 2025 to 45 days in the six months ended June 30, 2026, primarily due to the increase in our trade receivables, a significant portion of which arose from sales during the period and had not yet reached their contractual payment due dates.

Financial Information · p. 234

Overdue balances are reviewed regularly by senior management.

Financial Information · p. 234
The company's explanation, the adviser's view and the page in the filing: see Matters
1 / 15

Tell us